INTERNATIONAL BIOTECHNOLOGY TST PLC

Director's Dealing • Nov 2, 2021

National Storage Mechanism | Additional information

RNS Number : 0929R

Intl. Biotechnology Trust PLC

02 November 2021

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

The Company was notified today that Mr Patrick Magee, a non-executive Director of the Company, purchased 4,000 Ordinary 25p shares in the capital of the Company on 02 November 2021 at a price of 735 pence per Ordinary share. As a result of this purchase, Mr Magee's aggregate holding of shares in the Company is 7,500 Ordinary shares, representing 0.02% of the Company's issued share capital.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Patrick Magee

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

International Biotechnology Trust plc

b)

LEI

213800N1QUJ744P76D11

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares

GB0004559349

b)

Nature of the transaction

Share purchase

c)

Price(s) and volume(s)

Price(s)	Volume(s)
735p	4,000

d)

Aggregated information

-	Aggregated volume

-	Price

N/A

N/A

e)

Date of the transaction

02 November 2021

f)

Place of the transaction

London Stock Exchange                          

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBDBDBGDGDGBD